All Genzyme articles
-
Business
AstraZeneca sells off drugs to streamline portfolio
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus